Read + Share
Oppelt P, Ley JC, Worden F, Palka K, et al. Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related
oropharynx squamous-cell carcinoma: A multicenter phase 2 trial. Oral Oncol 2021;114:105164.
PMID: 33465681
|
 |
|
Oppelt P, Ley JC, Worden F, Palka K, et al. Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related
oropharynx squamous-cell carcinoma: A multicenter phase 2 trial. Oral Oncol 2021;114:105164.
PMID: 33465681
|
|
|
|